Latest Australian Markets News

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Locate Technologies secures court approval to transition its holding company to a newly listed New Zealand entity, marking a significant restructuring and ASX delisting.

S&P Dow Jones Indices has announced its December 2025 quarterly rebalance, introducing notable additions and removals across key S&P/ASX indices effective December 22. The reshuffle highlights shifts in market dynamics with fresh entrants and exits in major Australian stock indices.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Collins Foods has reported record half-year results driven by strong revenue growth, margin expansion, and operational excellence across its Australian and European markets. The company also raised its profit guidance and declared a higher interim dividend.

Collins Foods Limited reported solid half-year growth with revenue up 6.6% and net profit rising 12.7%, driven by strong performance in its KFC operations across Australia and Europe. The company declared a fully franked interim dividend of 13 cents per share, while navigating increased provisions linked to wage compliance and ongoing class action litigation.

Oneview Healthcare reported robust commercial growth in 2025, driven by new US client wins and the launch of its AI-powered care assistant, Ovie. The company enters 2026 with a confident outlook focused on expanding its US footprint and advancing digital health innovation.

EDU Holdings has significantly raised its FY25 financial outlook following strong enrolments and cost efficiencies, while announcing a selective buy-back of 12.5% of its shares from major investors.

Big River Industries Ltd has announced a fully underwritten renounceable entitlement offer to raise approximately $10 million, aimed at funding its acquisition of John’s Building Supplies, a leading Western Australian building materials distributor. The offer opens on December 8 and closes on December 17, 2025.

Haranga Resources has commenced underground diamond drilling at its Lincoln Gold Project in California, aiming to convert a historical resource to JORC compliance and explore new high-grade gold zones.

Algorae Pharmaceuticals has secured a key distribution agreement with global giant Dr. Reddy’s Laboratories to supply the chemotherapy drug Capecitabine in Australia, marking a significant step in its oncology commercialisation strategy.